{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:33:43Z","timestamp":1761809623094,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.jviscsurg.2020.01.008","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T08:18:52Z","timestamp":1580113132000},"page":"171-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcimimetics: Mechanisms of persistent commercial pressures on prescription of medications"],"prefix":"10.1016","volume":"157","author":[{"given":"L.","family":"Brunaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zarnegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0090","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jamcollsurg.2011.12.046","article-title":"Improved long-term survival of dialysis patients after near-total parathyroidectomy","volume":"214","author":"Sharma","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.surg.2018.07.043","article-title":"Changing landscape of the treatment of hyperparathyroidism related to end-stage renal disease-can we turn the clock backward?","volume":"165","author":"Kruijff","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0100","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2015.72","article-title":"Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"88","author":"Komaba","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0110","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"EVOLVE Trial Investigators CG","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0115","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/ndt\/gfx044","article-title":"Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review","volume":"32","author":"van der Plas","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.surg.2015.06.058","article-title":"Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis","volume":"159","author":"Brunaud","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0125","doi-asserted-by":"crossref","first-page":"e011482","DOI":"10.1136\/bmjopen-2016-011482","article-title":"Trajectories of CKD-MBD biochemical parameters over a 2-year period following diagnosis of secondary hyperparathyroidism: a pharmacoepidemiological study","volume":"7","author":"Filipozzi","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","article-title":"Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis","volume":"49","author":"Narayan","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.surg.2018.04.090","article-title":"Parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival","volume":"165","author":"Finnerty","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/SLA.0000000000003000","article-title":"The impact of corporate payments on robotic surgery research: a systematic review","volume":"269","author":"Criss","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0145","article-title":"Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases","volume":"367","author":"Goupil","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jviscsurg.2020.01.008_bib0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.295.4.429","article-title":"Health industry practices that create conflicts of interest: a policy proposal for academic medical centers","volume":"295","author":"Brennan","year":"2006","journal-title":"JAMA"},{"year":"2007","series-title":"On the take: how medicine's complicity with big business can endanger your health","author":"Kassirer","key":"10.1016\/j.jviscsurg.2020.01.008_bib0155"},{"year":"2019","series-title":"Le grand blues de la recherche publique","author":"Larousserie","key":"10.1016\/j.jviscsurg.2020.01.008_bib0160"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788620300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788620300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:31:04Z","timestamp":1761809464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878788620300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1878788620300291"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2020.01.008","relation":{},"ISSN":["1878-7886"],"issn-type":[{"type":"print","value":"1878-7886"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcimimetics: Mechanisms of persistent commercial pressures on prescription of medications","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2020.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}